146 related articles for article (PubMed ID: 1964823)
1. A series of novel, highly potent and selective agonists for the kappa-opioid receptor.
Hayes AG; Birch PJ; Hayward NJ; Sheehan MJ; Rogers H; Tyers MB; Judd DB; Scopes DI; Naylor A
Br J Pharmacol; 1990 Dec; 101(4):944-8. PubMed ID: 1964823
[TBL] [Abstract][Full Text] [Related]
2. GR94839, a kappa-opioid agonist with limited access to the central nervous system, has antinociceptive activity.
Rogers H; Birch PJ; Harrison SM; Palmer E; Manchee GR; Judd DB; Naylor A; Scopes DI; Hayes AG
Br J Pharmacol; 1992 Aug; 106(4):783-9. PubMed ID: 1327387
[TBL] [Abstract][Full Text] [Related]
3. Profile of activity of kappa receptor agonists in the rabbit vas deferens.
Hayes A; Kelly A
Eur J Pharmacol; 1985 Apr; 110(3):317-22. PubMed ID: 2988982
[TBL] [Abstract][Full Text] [Related]
4. A novel series of potent and selective agonists at the opioid kappa-receptor.
Costello GF; Main BG; Barlow JJ; Carroll JA; Shaw JS
Eur J Pharmacol; 1988 Jul; 151(3):475-8. PubMed ID: 2850924
[TBL] [Abstract][Full Text] [Related]
5. CI-977, a novel and selective agonist for the kappa-opioid receptor.
Hunter JC; Leighton GE; Meecham KG; Boyle SJ; Horwell DC; Rees DC; Hughes J
Br J Pharmacol; 1990 Sep; 101(1):183-9. PubMed ID: 2178014
[TBL] [Abstract][Full Text] [Related]
6. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. I. A mixed opioid agonist with potent antinociceptive activity.
Gengo PJ; Pettit HO; O'Neill SJ; Wei K; McNutt R; Bishop MJ; Chang KJ
J Pharmacol Exp Ther; 2003 Dec; 307(3):1221-6. PubMed ID: 14534368
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
8. Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
Scheurer U; Wenger F; Caliezi A; Drack E; Varga L; Halter F
J Pharmacol Exp Ther; 1990 Mar; 252(3):1324-30. PubMed ID: 1969475
[TBL] [Abstract][Full Text] [Related]
9. The mu, kappa and delta properties of various opioid agonists.
Takemori AE; Ikeda M; Portoghese PS
Eur J Pharmacol; 1986 Apr; 123(3):357-61. PubMed ID: 3013652
[TBL] [Abstract][Full Text] [Related]
10. Characterization of rabbit ear artery opioid receptors using a delta-selective agonist and antagonist.
Berzetei IP; Yamamura HI; Duckles SP
Eur J Pharmacol; 1987 Jul; 139(1):61-6. PubMed ID: 2820755
[TBL] [Abstract][Full Text] [Related]
11. Central and peripheral actions of the novel kappa-opioid receptor agonist, EMD 60400.
Barber A; Bartoszyk GD; Greiner HE; Mauler F; Murray RD; Seyfried CA; Simon M; Gottschlich R; Harting J; Lues I
Br J Pharmacol; 1994 Mar; 111(3):843-51. PubMed ID: 8019761
[TBL] [Abstract][Full Text] [Related]
12. Characterization of opioid receptors on smooth muscle cells from guinea pig stomach.
Zhang L; Gu ZF; Pradhan T; Jensen RT; Maton PN
Am J Physiol; 1992 Mar; 262(3 Pt 1):G461-9. PubMed ID: 1312793
[TBL] [Abstract][Full Text] [Related]
13. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.
Barber A; Bartoszyk GD; Bender HM; Gottschlich R; Greiner HE; Harting J; Mauler F; Minck KO; Murray RD; Simon M
Br J Pharmacol; 1994 Dec; 113(4):1317-27. PubMed ID: 7889287
[TBL] [Abstract][Full Text] [Related]
14. Opioid activity of dermenkephalin analogues in the guinea-pig myenteric plexus and the hamster vas deferens.
Sagan S; Corbett AD; Amiche M; Delfour A; Nicolas P; Kosterlitz HW
Br J Pharmacol; 1991 Oct; 104(2):428-32. PubMed ID: 1665735
[TBL] [Abstract][Full Text] [Related]
15. Activity profiles of dalargin and its analogues in mu-, delta- and kappa-opioid receptor selective bioassays.
Pencheva N; Pospisek J; Hauzerova L; Barth T; Milanov P
Br J Pharmacol; 1999 Oct; 128(3):569-76. PubMed ID: 10516634
[TBL] [Abstract][Full Text] [Related]
16. Hamster vas deferens contains delta-opioid receptors.
McKnight AT; Corbett AD; Marcoli M; Kosterlitz HW
Neuropeptides; 1984 Dec; 5(1-3):97-100. PubMed ID: 6099523
[TBL] [Abstract][Full Text] [Related]
17. Evidence that the kappa agonist U50488H has non-opioid actions.
Hayes AG; Birch PP; Cavicchini E
J Pharm Pharmacol; 1988 Oct; 40(10):718-20. PubMed ID: 2907540
[TBL] [Abstract][Full Text] [Related]
18. The choice of opioid receptor subtype in isolated preparations by ohmefentanyl.
Jin WQ; Chen XJ; Chi ZQ
Sci Sin B; 1987 Feb; 30(2):176-81. PubMed ID: 3039656
[TBL] [Abstract][Full Text] [Related]
19. Determination of the receptor selectivity of opioid agonists in the guinea-pig ileum and mouse vas deferens by use of beta-funaltrexamine.
Hayes AG; Sheehan MJ; Tyers MB
Br J Pharmacol; 1985 Dec; 86(4):899-904. PubMed ID: 3000501
[TBL] [Abstract][Full Text] [Related]
20. BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in mice.
Broom DC; Guo L; Coop A; Husbands SM; Lewis JW; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2000 Sep; 294(3):1195-200. PubMed ID: 10945877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]